Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.
| Current Price | ₹75.50 |
|---|---|
| Market Cap | ₹757 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 18.4 |
| Return on Equity | 12.10% |
| 52-Week Range | ₹67.00 – ₹114.90 |
| Beta (1Y) | 0.6 |
| Dividend Yield | 1.99% |
Anuh Pharma Ltd. is trading at ₹75.50, with a market capitalisation of ₹757 Cr.
Anuh Pharma Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Anuh Pharma Ltd. has a P/E of 18.4 and a return on equity of 12.10%.